Kaloba este un medicament de tip OTC (over-the -counter), ce are la baza extract standardizat din planta Pelargonium sidoides, recomandat pentru prevenirea si tratarea infectiilor tractului respirator: raceala, sinuzita, bronsita sau amigdalita.<\/p>\n
“Infectiile aparatului respirator au o frecventa ridicata (2\/3 din populatia generala raceste minim 1 data\/an, iar la copiii de 10 ani, frecventa fiind de 4 raceli\/an). Aceste infectii sunt provocate, in majoritatea cazurilor, de virusuri. Prin migrarea ascendenta sau descendenta a patogenilor, primele simptome inofensive se pot complica in sinuzite si\/sau bronsite acute”, a declarat medicul Ana Culcer, sefa clinicii de neonatologie a Spitalului Universitar de Urgenta.<\/p>\n
Doctorul Carmina Rogojinaru Smith, country manager al companiei Ewopharma, calcula anterior pentru BUSINESS Magazin taxele pe care le au de pl\u0103tit companiile farma: circa 20% din venituri taxa clawback, 5% diferen\u0163a de curs valutar \u00eentre leu \u015fi euro \u015fi 7% dob\u00e2nda la b\u0103nci pentru a asigura finan\u0163area timp de un an p\u00e2n\u0103 la plata medicamentelor de c\u0103tre stat. \u00cen total, mai bine de 30% din cifra de afaceri. “Cel mai probabil vor supravie\u0163ui produsele cu marje de peste 30%”, spunea atunci Smith, care anticipeaz\u0103 c\u0103 cele cu profitabilitate mai mic\u0103, de\u015fi utilizate de pacien\u0163i, nu vor mai putea fi sus\u0163inute mult timp. Marjele de profit pentru doctoriile Ewopharma sunt cuprinse, potrivit managerului, \u00eentre 10% \u015fi 50%, iar noul produs Kaloba, platit din buzunar, va contribui la cre\u015fterea fluxului de licidit\u0103\u0163i a companiei.<\/p>\n","protected":false},"excerpt":{"rendered":"
Kaloba, un nou medicament disponibil f\u0103r\u0103 re\u0163et\u0103 \u015fi care se pl\u0103te\u015fte din buzunarul pacientului, este un remediu impotriva infectiilor respiratorii, avand un mecanism de actiune antibacterian, antiviral, mucolitic si o actiune rapida, care reduce durata si severitatea simptomelor, previne recidiva si scurteaza perioada de revenire in activitate.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[29494,29495,7212],"class_list":["post-57941","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-ewopharma","tag-kaloba","tag-vanzari"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/57941","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57941"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/57941\/revisions"}],"predecessor-version":[{"id":74098,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/57941\/revisions\/74098"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57941"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57941"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57941"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}